How often does Integral Diagnostics pay dividends? What is the dividend yield for Integral Diagnostics?

Integral Diagnostics announced a Final dividend on Wednesday, August 30th. Stockholders of record on Tuesday, October 3rd will be paid a dividend of 0.035 per share on Tuesday, October 3rd. This represents a dividend yield of 1.15%. The ex-dividend date is Wednesday, August 30th. This is a positive change from the stock's previous Final dividend of A$0.03. Read our dividend analysis for IDX .

Is Integral Diagnostics a good dividend stock?

Integral Diagnostics (ASX:IDX) pays an annual dividend of A$0.07 per share and currently has a dividend yield of 4.22%. IDX has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 63.64%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for IDX .

What other stocks do shareholders of Integral Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Integral Diagnostics investors own include Gevo (GEVO) , Fluidigm (FLDM) , EML Payments (EML) , electroCore (ECOR) , Dynavax Technologies (DVAX) , CytoDyn (CYDY) , Chimerix (CMRX) , Capricor Therapeutics (CAPR) , Bathurst Resources (BRL) and Athersys (ATHX) .

Integral Diagnostics Stock Price, News & Analysis (ASX:IDX)

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 240,828 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: 4.22%
Price Target: N/A

About Integral Diagnostics Stock (ASX:IDX)

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.

IDX Stock News Headlines

November 23, 2023 | morningstar.com

Integral Diagnostics Ltd IDX

November 2, 2023 | fool.com.au

Guess which ASX All Ords share is crashing 30% today

December 2, 2023 | DTI Trader (Ad)

New CBOE “special perk” helps traders target income every weekend

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

November 2, 2023 | finance.yahoo.com

Investors in Integral Diagnostics (ASX:IDX) have unfortunately lost 34% over the last three years

August 30, 2023 | finance.yahoo.com

Integral Diagnostics' (ASX:IDX) Dividend Will Be Increased To A$0.035

August 28, 2023 | afr.com

What we learnt: Appen, NextDC, Helloworld, Integral Diagnostics

August 20, 2023 | finance.yahoo.com

A Look At The Fair Value Of Integral Diagnostics Limited (ASX:IDX)

May 23, 2023 | finance.yahoo.com

Integral Diagnostics (ASX:IDX) shareholders have earned a 8.1% CAGR over the last five years

December 2, 2023 | DTI Trader (Ad)

New CBOE “special perk” helps traders target income every weekend

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

May 8, 2023 | finance.yahoo.com

Integral Diagnostics Limited (ASX:IDX) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead

May 8, 2023 | finance.yahoo.com

Integral Diagnostics Limited (ASX:IDX) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

April 24, 2023 | finance.yahoo.com

Integral Diagnostics Limited (ASX:IDX) most popular amongst individual investors who own 57% of the shares, institutions hold 32%

April 10, 2023 | finance.yahoo.com

Great news for Integral Diagnostics Limited (ASX:IDX): Insiders acquired stock in large numbers last year

March 13, 2023 | finance.yahoo.com

Calculating The Fair Value Of Integral Diagnostics Limited (ASX:IDX)

February 26, 2023 | finance.yahoo.com

Why It Might Not Make Sense To Buy Integral Diagnostics Limited (ASX:IDX) For Its Upcoming Dividend

February 18, 2023 | finance.yahoo.com

Integral Diagnostics First Half 2023 Earnings: EPS: AU$0.069 (vs AU$0.051 in 1H 2022)

February 17, 2023 | fool.com.au

Why Baby Bunting, Integral Diagnostics, Pilbara Minerals, and Zip shares are falling

February 1, 2023 | benzinga.com

Digital Diagnostics and Tamer Healthcare Announce Strategic Partnership in the Kingdom of Saudi Arabia

December 31, 2022 | fool.com

Fulgent Genetics (NASDAQ: FLGT)

December 22, 2022 | finance.yahoo.com

Should You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?

November 30, 2022 | finance.yahoo.com

Integral Diagnostics (ASX:IDX) shareholders have endured a 41% loss from investing in the stock a year ago

November 4, 2022 | finance.yahoo.com

Institutions profited after Integral Diagnostics Limited's (ASX:IDX) market cap rose AU$61m last week butindividual investors profited the most

October 7, 2022 | finance.yahoo.com

Bullish Integral Diagnostics Limited (ASX:IDX) insiders filled their treasuries with AU$810k worth of stock over last year

September 23, 2022 | finance.yahoo.com

Is Integral Diagnostics Limited (ASX:IDX) Trading At A 43% Discount?

September 17, 2022 | afr.com

Integral Diagnostics Limited

August 30, 2022 | fool.com.au

3 ASX shares now at a golden buying opportunity: experts

August 16, 2022 | reuters.com

Integral Diagnostics Ltd

See More Headlines

Receive IDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integral Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 10/3 Dividend: 8/30/2023
Dividend Payable: 10/03/2023
Today: 12/02/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: ASX
Industry: Diagnostics & Research
Sub-Industry: N/A
Sector: Medical
Current Symbol: ASX:IDX
CUSIP: N/A
CIK: N/A
Web: www.integraldiagnostics.com.au
Phone: 61 3 5339 0704
Fax: N/A
Employees: 2,010
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): A$0.11
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: 1.39
Net Income: $25.04 million
Net Margins: 5.68%
Pretax Margin: N/A
Return on Equity: 6.95%
Return on Assets: 3.07%

Debt

Debt-to-Equity Ratio: 97.86
Current Ratio: 0.76
Quick Ratio: 1.84

Sales & Book Value

Annual Sales: $440.76 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 23.99
Book Value: A$1.60 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 233,470,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 0.95

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Dr. Ian Kadish M.B.A. (Age 60)
MBBCh, CEO, MD & Director
Comp: $930.5k
Mr. Craig White
Chief Financial Officer

Key Competitors

View All Competitors

Insiders

IDX Stock Analysis - Frequently Asked Questions

How often does Integral Diagnostics pay dividends? What is the dividend yield for Integral Diagnostics?: Integral Diagnostics announced a Final dividend on Wednesday, August 30th. Stockholders of record on Tuesday, October 3rd will be paid a dividend of 0.035 per share on Tuesday, October 3rd. This represents a dividend yield of 1.15%. The ex-dividend date is Wednesday, August 30th. This is a positive change from the stock's previous Final dividend of A$0.03.
Read our dividend analysis for IDX.
Is Integral Diagnostics a good dividend stock?: Integral Diagnostics (ASX:IDX) pays an annual dividend of A$0.07 per share and currently has a dividend yield of 4.22%. IDX has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 63.64%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for IDX.
What other stocks do shareholders of Integral Diagnostics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Integral Diagnostics investors own include Gevo (GEVO), Fluidigm (FLDM), EML Payments (EML), electroCore (ECOR), Dynavax Technologies (DVAX), CytoDyn (CYDY), Chimerix (CMRX), Capricor Therapeutics (CAPR), Bathurst Resources (BRL) and Athersys (ATHX).

This page (ASX:IDX) was last updated on 12/2/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial